Currently, out of the existing stock ratings of Leah Cann - 2708 which are a Buy (98.76%), 34 which are a Hold (1.24%)

Leah Cann

Work Performance Price Targets & Ratings Chart

Analyst Leah Cann works at BROOKLINE and is covering the Healthcare sector with 130 price targets and ratings displayed on 14 stocks. Previously, Leah Cann worked at OPPENHEIMER.

Leah Cann's average stock forecast success ratio is 41.67% with an average time for price targets to be met of 191.5 days.

Most recent stock forecast was given on MRNA, Moderna at 22-Jun-2022.

Wall Street Analyst Leah Cann

Analyst best performing recommendations are on SYRS.
The best stock recommendation documented was for MRNA (MODERNA) at 11/25/2020. The price target of $164 was fulfilled within 13 days with a profit of $54.82 (50.21%) receiving and performance score of 38.62.

Average potential price target upside

AMGN Amgen CELG CTIC CTI BioPharma MEIP MEI Pharma MRNA Moderna SQZ SQZ Biotechnologies Company CCCC C4 Therapeutics CRBU KURA Kura Oncology SYRS MRTX Mirati Therapeutics NTLA Intellia Therapeutics VSTM Verastem XFOR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

260

$-11.46 (-4.22%)

260

16 days ago

17/17 (100%)

$43.7 (28.65%)

714

Buy

310

$38.54 (14.20%)

295

1 months 7 days ago

21/24 (87.5%)

$48.4 (31.11%)

728

Hold

223

$-48.46 (-17.85%)

208

1 months 7 days ago

13/17 (76.47%)

$15.67 (12.28%)

414

Hold

253

$-18.46 (-6.80%)

254

1 months 17 days ago

12/12 (100%)

$9.5 (5.69%)

190

Buy

280

$8.54 (3.15%)

280

1 months 27 days ago

13/21 (61.9%)

$44.69 (20.29%)

572

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Leah Cann?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart